OMIM Phenotype&GeneSymbol  

  Chapter.20   External causes of morbidity and mortality (V01-Y98)
  Y40-Y59   Drugs, medicaments and biological substances causing adverse effects in therapeutic use
    Y51   Drugs primarily affecting the autonomic nervous system ( Search )
    • Y510   Anticholinesterase agents ( Search )
    • Y511   Other parasympathomimetics [cholinergics] ( Search )
    • Y512   "Ganglionic blocking drugs, not elsewhere classified" ( Search )
    • Y513   "Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified" ( Search )
    • Y514   "Predominantly alpha-adrenoreceptor agonists, not elsewhere classified" ( Search )
    • Y515   "Predominantly beta-adrenoreceptor agonists, not elsewhere classified" ( Search )
    • Y516   "Alpha-adrenoreceptor antagonists, not elsewhere classified" ( Search )
    • Y517   "Beta-adrenoreceptor antagonists, not elsewhere classified" ( Search )
    • Y518   "Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified" ( Search )
    • Y519   Other and unspecified drugs primarily affecting the autonomic nervous system ( Search )
Copyright©Ministry of Health, Labour and Welfare, All Rights reserved.